Results 121 to 130 of about 3,573 (200)

Permanent visual impairment following a Behçet's disease flare while on calcitonin gene-related peptide receptor antagonist therapy: a case report. [PDF]

BMC Ophthalmol
Khan FA, Malik A, Nelson E, Fahimdanesh K, Kaur K, Elison J, Sayed M.   +6 more
europepmc   +1 more source

Decoding the long-term safety of anti-CGRP (receptor) mAbs: a meta-analysis and systematic review. [PDF]

J Headache Pain
Hoehne CL, Overeem LH, Sanchez-Del-Rio M, Deligianni C, Gil-Gouveia R, Versijpt J, Amin FM, Lampl C, Ryliskiene K, Tronvik E, Coppola G, Holland PR, MaassenVanDenBrink A, Martelletti P, Reuter U, European Headache Federation, EHF.   +16 more
europepmc   +1 more source

Long-term effectiveness of fremanezumab in episodic and chronic migraine patients in clinical routine - 24-months results from the prospective non-interventional FINESSE study. [PDF]

J Headache Pain
Straube A, Broessner G, Gaul C, Hamann X, Heinze A, Kraya T, Neeb L.   +6 more
europepmc   +1 more source

Assessing the Occurrence of Hypertension in Patients Receiving Calcitonin Gene-Related Peptide Monoclonal Antibodies for Episodic and Chronic Migraine: A Systematic Review. [PDF]

Cureus
Kakde SP, Islam K, Ali MF, Anwar MS, Nadeem L, Rana AR, Rana AW, Hayat SK, Ali SM, Kolanu ND.   +9 more
europepmc   +1 more source

Efficacy and Safety of Erenumab in Adults With Medication Overuse Headache: Final Results From a Phase 4 Randomized Placebo-Controlled Study. [PDF]

Eur J Neurol
Tepper SJ, Dodick DW, Lanteri-Minet M, Dolezil D, Gil-Gouveia R, Lucas C, Piasecka-Stryczynska K, Szabó G, Mikol DD, Chehrenama M, Chou DE, Liu Z, da Silva Lima GP.   +12 more
europepmc   +1 more source

Changes in interictal cerebral blood flow observed in migraine patients who respond to anti-calcitonin gene-related peptide therapy. [PDF]

Sci Rep
Shimoda M, Hoshikawa K, Oda S, Imai M, Aoki R, Shinohara C.   +5 more
europepmc   +1 more source

Persistence, switching, and healthcare use after initiating calcitonin gene-related peptide inhibitors: a real-world assessment. [PDF]

J Headache Pain
Moura CS, Randall JR, Klarenbach S, Behlouli H, Luu H, Amoozegar F, Kaboré JL, Bernatsky S.   +7 more
europepmc   +1 more source

Prescription of Monoclonal Antibodies Against Calcitonin Gene-Related Peptide for the Prophylaxis of Migraine in Austria: A Retrospective, Longitudinal Analysis of Nationwide Insurance Data. [PDF]

Eur J Neurol
Zebenholzer K, Gleiss A, Reichardt B, Gall W, Wöber C.   +4 more
europepmc   +1 more source

Number Needed to Treat and Cost Per Responder Analysis of Anti-CGRP Monoclonal Antibodies for Migraine Prevention in Adults for Whom Prior Preventive Treatments have Failed. [PDF]

Adv Ther
Mitsikostas DD, Awad SF, Kongerslev R, Boserup LP, Lee XY, Phul R, Sacco S.   +6 more
europepmc   +1 more source

A Semi-Mechanistic Mathematical Model of Immune Tolerance Induction to Support Preclinical Studies of Human Monoclonal Antibodies in Rats. [PDF]

Pharmaceutics
Gupta P, Ryman JT, Jawa V, Meibohm B.
europepmc   +1 more source